All In MedTech

Device Trial Radar · NCT07096856

Post Market Clinical Study to Evaluate the Performance of the Versius Surgical System

Last checked: Nov 19, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Mar 23, 2026

Primary completion

Mar 30, 2027

Study completion Apr 30, 2027

Sponsor

Lead sponsor
CMR Surgical LtdNot on our public-company list
Sponsor type
Industry
First posted
Jul 31, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn how the Versius Surgical System, a robotic surgery device, works for gallbladder removal surgery (cholecystectomy) in adults. The main questions it aims to answer are: How often can the surgery be successfully completed using Versius without needing to switch to a different surgical method? What serious complications, if any, occur within 30 days after surgery? Researchers will collect information from adult patients who have gallbladder surgery using the Versius system in U.S. hospitals. The purpose is to better understand how the device performs and how patients recover after surgery. Participants will: Be adults age 22 or older who are eligible for minimally invasive gallbladder surgery Undergo robotic-assisted surgery using the Versius Surgical System Allow the research team to collect data during surgery and up to 30 days after Complete standard follow-up visits after discharge Patients with certain medical conditions, such as cancer, high BMI (≥40 kg/m²), or contraindications to anesthesia or robotic surgery, will not be included in the study. This study is sponsored by CMR Surgical Ltd., the manufacturer of the Versius system.

Conditions

  • Cholecystectomy, Robotic

Interventions

  • Robotic assisted cholecystectomyDevice

    Robotic assisted cholecystectomy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of successful completion of the cholecystectomy surgical procedure without unplanned conversions to open or other minimally invasive surgeryTime frame: From start of surgery to end of procedure
  2. Rate of serious adverse events up to 30 days post procedure.Time frame: From end of surgery through 30 days post-procedure

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Cedar-Sinai Heatlh Sciences University

    Los Angeles, California · Recruiting

  • University of California San Diego Health

    San Diego, California · Recruiting

  • University of Texas Health Science Center at Houston

    Houston, Texas · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.